NPI: 1215332945 · RIVERSIDE, CA 92505 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,369 | $237K |
| 2019 | 32,218 | $1.75M |
| 2020 | 28,919 | $1.73M |
| 2021 | 28,390 | $1.59M |
| 2022 | 31,945 | $1.50M |
| 2023 | 38,254 | $2.17M |
| 2024 | 26,288 | $2.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90945 | 138,196 | 4,753 | $10.26M | |
| 90999 | 15,276 | 719 | $635K | |
| A4657 | Syringe w/wo needle | 2,078 | 2,034 | $64K |
| 82728 | 3,078 | 3,007 | $27K | |
| Q4081 | Epoetin alfa, 100 units esrd | 10,239 | 3,274 | $23K |
| 0250 | 2,345 | 1,115 | $22K | |
| 90993 | 83 | 30 | $19K | |
| 82570 | 1,549 | 711 | $4K | |
| 82306 | 246 | 246 | $2K | |
| 83540 | 3,086 | 3,012 | $752.68 | |
| 90661 | 22 | 22 | $678.04 | |
| 85048 | 3,084 | 3,001 | $34.18 | |
| 83970 | 3,079 | 3,002 | $0.00 | |
| J1756 | Iron sucrose injection | 3,481 | 2,877 | $0.00 |
| 85041 | 3,090 | 3,008 | $0.00 | |
| J0887 | Epoetin beta esrd use | 549 | 500 | $0.00 |
| 83550 | 2,472 | 2,400 | $0.00 | |
| G0008 | Admin influenza virus vac | 85 | 83 | $0.00 |
| 84540 | 439 | 372 | $0.00 | |
| G0499 | Hepb screen high risk indiv | 692 | 537 | $0.00 |
| 90674 | 181 | 172 | $0.00 | |
| 90747 | 13 | 13 | $0.00 | |
| J0604 | Cinacalcet, esrd on dialysis | 20 | 13 | $0.00 |